Additional Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Temple TX. 76508
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Naples FL. 34102
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    San Francisco CA. 94143
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Durham NC. 27710
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Los Angeles CA. 90033
    View Details

  • A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

    GSK Investigational Site
    Los Angeles CA. 90095
    View Details

  • Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease

    MGH Institute of Health Professions
    Charlestown MA. 02129
    View Details

  • Advanced Imaging for Pulmonary Fibrosis

    Massachusetts General Hospital
    Boston MA. 02114
    View Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    Washington University (Site #: 71157)
    St Louis MO. 63130
    View Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    NYU Langone Health (Site #: 71177)
    New York NY. 10016
    View Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    University of Pennsylvania (Site #: 71111)
    Philadelphia PA. 19104
    View Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    Cincinnati Children's Hospital Medical Center (Site #: 71017)
    Cincinnati OH. 45229
    View Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    University of California, Los Angeles (Site #: 71123)
    Los Angeles CA. 90095
    View Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    Cleveland Clinic (Site #: 71101)
    Cleveland OH. 44195
    View Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    Johns Hopkins (Site #: 71119)
    Baltimore MD. 21287
    View Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    Duke University (Site #: 71139)
    Durham NC. 27710
    View Details

  • Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

    MD Anderson Cancer Center
    Houston TX. 77030
    View Details

  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Montreal QC. H2X 0A9
    View Details

  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Trois-Rivières QC. G8T 7A1
    View Details